Literature DB >> 14696063

Perfect count: a novel approach for the single platform enumeration of absolute CD4+ T-lymphocytes.

Ian Storie1, Alex Sawle, Karen Goodfellow, Liam Whitby, Vivian Granger, Rosalie Y Ward, Janet Peel, Theresa Smart, John T Reilly, David Barnett.   

Abstract

BACKGROUND: The derivation of reliable CD4(+) T lymphocyte counts is vital for the monitoring of disease progression and therapeutic effectiveness in HIV(+) individuals. Flow cytometry has emerged as the method of choice for CD4(+) T lymphocyte enumeration, with single-platform technology, coupled with reference counting beads, fast becoming the "gold standard." However, although single-platform, bead-based, sample acquisition requires the ratio of beads to cells to remain unchanged, there is no available method, until recently, to monitor this.
METHODS: Perfect Count beads have been developed to address this issue and to incorporate two bead populations, with different densities, to allow the detection of inadequate mixing. Comparison of the relative proportions of both beads with the manufacture's defined limits enables an internal QC check during sample acquisition. In this study, we have compared CD4(+) T lymphocyte counts, obtained from 104 HIV(+) patients, using TruCount beads with MultiSet software (defined as the predicated method) and the new Perfect Count beads, incorporating an in house sequential gating strategy.
RESULTS: We have demonstrated an excellent degree of correlation between the predicate method and the Perfect Count system (r(2) = 0.9955; Bland Altman bias +27 CD4(+) T lymphocytes/microl).
CONCLUSIONS: The Perfect Count system is a robust method for performing single platform absolute counts and has the added advantage of having internal QC checks. Such an approach enables the operator to identify potential problems during sample preparation, acquisition and analysis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14696063     DOI: 10.1002/cyto.b.10065

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  7 in total

1.  ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.

Authors:  U Koehl; K Bochennek; R Esser; A Brinkmann; R Quaritsch; M Becker; J Soerensen; P Bader; D Schwabe; T Klingebiel; J Fischer; S Y Zimmermann
Journal:  Int J Hematol       Date:  2007-12-18       Impact factor: 2.490

2.  Evaluation of a multicolor, single-tube technique to enumerate lymphocyte subpopulations.

Authors:  F Colombo; A Cattaneo; R Lopa; P Portararo; P Rebulla; L Porretti
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

Review 3.  CD4 immunophenotyping in HIV infection.

Authors:  David Barnett; Brooke Walker; Alan Landay; Thomas N Denny
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

4.  Nanowire array chips for molecular typing of rare trafficking leukocytes with application to neurodegenerative pathology.

Authors:  Minsuk Kwak; Dong-Joo Kim; Mi-Ri Lee; Yu Wu; Lin Han; Sang-Kwon Lee; Rong Fan
Journal:  Nanoscale       Date:  2014-06-21       Impact factor: 7.790

Review 5.  CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Authors:  Rosanna W Peeling; Kimberly A Sollis; Sarah Glover; Suzanne M Crowe; Alan L Landay; Ben Cheng; David Barnett; Thomas N Denny; Thomas J Spira; Wendy S Stevens; Siobhan Crowley; Shaffiq Essajee; Marco Vitoria; Nathan Ford
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

6.  Comparison of six different methods to calculate cell densities.

Authors:  Carolina Camacho-Fernández; David Hervás; Alba Rivas-Sendra; Mª Pilar Marín; Jose M Seguí-Simarro
Journal:  Plant Methods       Date:  2018-04-16       Impact factor: 4.993

7.  CD4(+)CD25(High) Treg cells in HIV/HTLV co-infected patients with neuropathy: high expression of Alpha4 integrin and lower expression of Foxp3 transcription factor.

Authors:  Raquel Matavele Chissumba; Suse Dayse Silva-Barbosa; Ângelo Augusto; Cremildo Maueia; Nédio Mabunda; Eduardo Samo Gudo; Nilesh Bhatt; Ilesh Jani; Wilson Savino
Journal:  BMC Immunol       Date:  2015-09-02       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.